The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling of metastatic lung squamous cell carcinoma (mLUSC) to identify patients with differential response to immune checkpoint inhibitor (ICI) therapy.
 
Daniel Boiarsky
No Relationships to Disclose
 
Lingzhi Hong
No Relationships to Disclose
 
Alissa Cooper
Honoraria - Ideology Health; Intellisphere; MedStar Health; MJH Life Sciences; Physician's Education Resource, LLC
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Regeneron
Research Funding - Abbvie (Inst); Amgen (Inst); Merck (Inst); Monte Rosa Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Guidepoint Inc; Regeneron
 
Maliazurina Saad
No Relationships to Disclose
 
Arielle Elkrief
Honoraria - Astrazeneca; Bristol-Myers Squibb; EMD Serono; Merck
Consulting or Advisory Role - Bristol Myers Squibb
Research Funding - AstraZeneca (Inst); Kanvas Bioscience (Inst); Merck (Inst)
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Alessandro Di Federico
Honoraria - Society for Immunotherapy of Cancer
Consulting or Advisory Role - Hanson Wade; Novartis
 
Muhammad Aminu
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Jeff Lewis
No Relationships to Disclose
 
Don Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar; Revolution Medicines
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Lilly; Menarini; Onconova Therapeutics; Sanofi
Research Funding - Astellas Pharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen; Mirati Therapeutics (Inst); NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
Ara Vaporciyan
No Relationships to Disclose
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ABION; Allyst; ArriVent Biopharma; ArriVent Biopharma; AstraZeneca; Aviston; Bayer; Black Diamond Therapeutics; BlossomHill Therapeutics; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Merus; Novartis; PineTree; Regeneron; Spectrum Pharmaceuticals; Systimmune; Taiho Pharmaceutical
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); EMD Serono (Inst); Janssen (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Johnson & Johnson/Janssen; Regeneron; Spectrum Pharmaceuticals
 
J. Jack Lee
No Relationships to Disclose
 
John Heymach
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; DAVA Pharmaceuticals; EMD Serono; Genentech/Roche; GlaxoSmithKline; Hengrui Pharmaceutical; Janssen; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; Nexus Health Systems; Pneuma Respiratory; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - DAVA Pharmaceuticals; IDEOlogy Health; MJH Life Sciences
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Mirati Therapeutics; Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations; Patents pending regarding subtyping of SCLC lung cancer.
 
Jia Wu
No Relationships to Disclose
 
Mark Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Coherus Biosciences; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation
 
Adam Schoenfeld
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Enara Bio; Heat Biologics; Immunocore; Iovance Biotherapeutics; Johnson & Johnson/Janssen; KSQ Therapeutics; Legend Biotech; Lyell Immunopharma; Merck; Oppenheimer; Perceptive Advisors; Prelude Therapeutics; Umoja Biopharma
Research Funding - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Jianjun Zhang
Honoraria - BeiGene; CancerNet; Geneplus; Geneplus; Hengrui Medicine; Innovent Biologics; innovent biologics; Innovent Biologics; Origimed; Roche; Roche China; Sino-USA Biomedical Platform; Suzhou Medical Association; Takeda; Varian Medical Systems; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Hunan Cancer Hospital; Johnson & Johnson/Janssen; Novartis
Research Funding - Helius; Merck; Novartis; Summit Therapeutics
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
Natalie Vokes
Honoraria - Cardinal Health; Guardant Health; HMP; Medlive; OMNI Health Media; OncLive/MJH Life Sciences; PlatformQ Health; Sanofi; Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; EMD Serono; ImmunityBio; Lilly; OncoCyte; Oncohost; Pfizer; Regeneron; Remedy Health; Sanofi; Sanofi/Regeneron; Summit pharmaceuticals; Tempus; Xencor
Research Funding - Amgen; Bristol Myers Squibb; Circulo; EMD Serono/Merck; IDEAYA Biosciences; Mirati Therapeutics; OncoCyte; Summit Health
Travel, Accommodations, Expenses - Regeneron